{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:53:19Z","timestamp":1790837599427,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1124\/jpet.118.252759","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T17:25:15Z","timestamp":1547227515000},"page":"47-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"title":["Ferroptosis as a Novel Therapeutic Target for Friedreich\u2019s Ataxia"],"prefix":"10.1016","volume":"369","author":[{"given":"M. Grazia","family":"Cotticelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taehee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Terrab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wipf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M","family":"Huryn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.252759_bib1","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1096\/fj.09-143222","article-title":"Does oxidative stress contribute to the pathology of Friedreich\u2019s ataxia? A radical question","volume":"24","author":"Armstrong","year":"2010","journal-title":"FASEB J"},{"key":"10.1124\/jpet.118.252759_bib2","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1038\/sj.onc.1204436","article-title":"Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms","volume":"20","author":"Belmokhtar","year":"2001","journal-title":"Oncogene"},{"key":"10.1124\/jpet.118.252759_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/hmg\/9.2.275","article-title":"Clinical, biochemical and molecular genetic correlations in Friedreich\u2019s ataxia","volume":"9","author":"Bradley","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.118.252759_bib4","doi-asserted-by":"crossref","first-page":"e6379","DOI":"10.1371\/journal.pone.0006379","article-title":"The first cellular models based on frataxin missense mutations that reproduce spontaneously the defects associated with Friedreich ataxia","volume":"4","author":"Calmels","year":"2009","journal-title":"PLoS One"},{"key":"10.1124\/jpet.118.252759_bib5","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ncl.2013.05.002","article-title":"Clinical neurogenetics: Friedreich ataxia","volume":"31","author":"Collins","year":"2013","journal-title":"Neurol Clin"},{"key":"10.1124\/jpet.118.252759_bib6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.redox.2013.06.004","article-title":"Insights into the role of oxidative stress in the pathology of Friedreich ataxia using peroxidation resistant polyunsaturated fatty acids","volume":"1","author":"Cotticelli","year":"2013","journal-title":"Redox Biol"},{"key":"10.1124\/jpet.118.252759_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/1087057111427949","article-title":"Primary and secondary drug screening assays for Friedreich ataxia","volume":"17","author":"Cotticelli","year":"2012","journal-title":"J Biomol Screen"},{"key":"10.1124\/jpet.118.252759_bib8","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1038\/s41598-018-23168-x","article-title":"Identification of p38 MAPK as a novel therapeutic target for Friedreich\u2019s ataxia","volume":"8","author":"Cotticelli","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.118.252759_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/1531-8249(199905)45:5<673::AID-ANA20>3.0.CO;2-Q","article-title":"Direct evidence that mitochondrial iron accumulation occurs in Friedreich ataxia","volume":"45","author":"Delatycki","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.118.252759_bib10","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1124\/jpet.118.252759_bib11","doi-asserted-by":"crossref","first-page":"487534","DOI":"10.1155\/2013\/487534","article-title":"Neurodegeneration in Friedreich\u2019s ataxia: from defective frataxin to oxidative stress","volume":"2013","author":"Gomes","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"10.1124\/jpet.118.252759_bib12","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/hmg\/11.24.3055","article-title":"A cellular model for Friedreich ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy","volume":"11","author":"Jauslin","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.118.252759_bib13","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.addr.2009.06.008","article-title":"Mitochondrial targeting of electron scavenging antioxidants: regulation of selective oxidation vs random chain reactions","volume":"61","author":"Kagan","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/jpet.118.252759_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/NEN.0b013e31827e5762","article-title":"Friedreich ataxia: neuropathology revised","volume":"72","author":"Koeppen","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1124\/jpet.118.252759_bib15","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1242\/dmm.030502","article-title":"Early cerebellar deficits in mitochondrial biogenesis and respiratory chain complexes in the KIKO mouse model of Friedreich ataxia","volume":"10","author":"Lin","year":"2017","journal-title":"Dis Model Mech"},{"key":"10.1124\/jpet.118.252759_bib16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ana.1001","article-title":"Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich\u2019s ataxia","volume":"49","author":"Lodi","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.118.252759_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0014-5793(02)02251-2","article-title":"Frataxin knockin mouse","volume":"512","author":"Miranda","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.118.252759_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ng1097-215","article-title":"Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia","volume":"17","author":"R\u00f6tig","year":"1997","journal-title":"Nat Genet"},{"key":"10.1124\/jpet.118.252759_bib19","first-page":"2033","article-title":"Establishing primary adult fibroblast cultures from rodents","volume":"44","author":"Seluanov","year":"2010","journal-title":"J Vis Exp"},{"key":"10.1124\/jpet.118.252759_bib20","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/ja411006a","article-title":"Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models","volume":"136","author":"Skouta","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1124\/jpet.118.252759_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"10.1124\/jpet.118.252759_bib22","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1021\/ja053679l","article-title":"Mitochondrial targeting of selective electron scavengers: synthesis and biological analysis of hemigramicidin-TEMPO conjugates","volume":"127","author":"Wipf","year":"2005","journal-title":"J Am Chem Soc"},{"key":"10.1124\/jpet.118.252759_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/hmg\/8.3.425","article-title":"The Friedreich\u2019s ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis","volume":"8","author":"Wong","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.118.252759_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/15230860050192233","article-title":"Sensitivity of FRDA lymphoblasts to salts of transition metal ions","volume":"2","author":"Wong","year":"2000","journal-title":"Antioxid Redox Signal"},{"key":"10.1124\/jpet.118.252759_bib25","doi-asserted-by":"crossref","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.118.252759_bib26","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/mds.27353","article-title":"Randomized, clinical trial of RT001: early signals of efficacy in Friedreich\u2019s ataxia","volume":"33","author":"Zesiewicz","year":"2018","journal-title":"Mov Disord"},{"key":"10.1124\/jpet.118.252759_bib27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","article-title":"On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death","volume":"3","author":"Zilka","year":"2017","journal-title":"ACS Cent Sci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524259620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524259620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.252759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:59:14Z","timestamp":1739962754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524259620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0022356524259620"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.252759","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ferroptosis as a Novel Therapeutic Target for Friedreich\u2019s Ataxia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.252759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}